FIELD: chemistry.
SUBSTANCE: invention represents pharmaceutical composition for correction and therapy of manifestations of amyloid intoxication in patients with brain pathologies, which are characterised by the fact that it contains melatonin 3-10 mg and memantine 5-300 mg.
EFFECT: effective treatment of patients, including cases of moderate cognitive disorders.
4 cl, 2 ex, 6 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
PHARMACEUTICAL COMPOSITION CONTAINING THE COMBINATION OF MEMANTINE AND MELATONIN | 2016 |
|
RU2654713C1 |
COMBINATION FOR TREATING AND PREVENTING BEHAVIOURAL, MENTAL, COGNITIVE AND NEUROLOGICAL DISORDERS ACCOMPANYING ORGANIC CNS DISEASES | 2012 |
|
RU2493838C1 |
METHOD FOR TREATMENT OF NEUROPATHIC PAIN | 2021 |
|
RU2780139C1 |
APPLICATION OF PROTEIN YB-1 AND ITS FRAGMENTS FOR PRODUCTION OF MEDICATIONS IN TREATMENT OF ALZHEIMER'S DISEASE | 2013 |
|
RU2561050C2 |
COMPOSITION FOR TREATING OR PREVENTING NEURODEGENERATIVE DISORDERS | 2012 |
|
RU2699038C2 |
URACIL DERIVATIVE AGENT FOR THERAPY OF ALZHEIMER DISEASE | 2014 |
|
RU2565756C1 |
COMPOSITION AND METHOD FOR INHIBITING ACCUMULATION, AGGREGATION AND FORMATION OF TAU PROTEIN COILS | 2020 |
|
RU2818590C1 |
PEPTIDE COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE | 2021 |
|
RU2816119C1 |
COMPOSITION, CONTAINING EXTRACT OF PORIA COCOSUM TISSUE, INTENDED FOR PREVENTION, RELIEF AND TREATMENT OF NEURODEGENERATIVE DISORDERS | 2015 |
|
RU2678982C2 |
Authors
Dates
2014-12-20—Published
2013-10-21—Filed